Lineage Cell Therapeutics, Inc.
LCTX.TA
Exchange: | TA |
Currency | Israeli Agora |
Fiscal Year End: | December |
Sector: | Healthcare |
Industry: | Biotechnology |
Gic Sector: | Energy |
Gic Group: | Energy |
Gic Industry: | Oil, Gas & Consumable Fuels |
Gic Sub Industry: | Coal & Consumable Fuels |
Description: | Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for unmet medical needs in the United States and internationally. The company develops Op Regen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the treatment of cervical spinal cord injuries; and VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers ANP1, an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of debilitating hearing loss; and PNC1, an allogeneic photoreceptor cell transplant, which is in preclinical development for the treatment of vision loss due to photoreceptor dysfunction or damage. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Immunomic Therapeutics, Inc., for the treatment of glioblastoma multiforme. The company was formerly known as Bio Time, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California. |
Address: | 2173 Salk Avenue, Carlsbad, CA, United States, 92008 |
Website: | https://www.lineagecell.com |
Full Time Employees: | 68 |
Updated On: | 2024-11-05 |
Highlights
Market Capitalization: | 587487808 |
Market Capitalization Mln: | 587.48 |
EBITDA: | -21397000 |
Book Value: | 0.36 |
Earnings Share: | -0.51 |
Most Recent Quarter: | 2024-06-30 |
Operating Margin TTM: | -4.16 |
Return On Assets TTM: | -0.12 |
Return On Equity TTM: | -0.35 |
Revenue TTM: | 6186000 |
Revenue Per Share TTM: | 0.03 |
Quarterly Revenue Growth YOY: | -0.56 |
Diluted Eps TTM: | -0.51 |
Valuation
Price Sales TTM: | 94.97 |
Price Book MRQ: | 2.18 |
Enterprise Value: | 459760924 |
Enterprise Value Revenue: | 19.85 |
Enterprise Value Ebitda: | -35.61 |
Shares
Shares Outstanding: | 188836992 |
Shares Float: | 146337635 |
Percent Insiders: | 0.44 |
Percent Institutions: | 50.35 |
Technicals
Beta: | 1.26 |
52 Week High: | 570 |
52 Week Low: | 3.38 |
50 Day MA: | 3.32 |
200 Day MA: | 3.84 |
Earnings
Report Date: | 2025-05-07 |
Date: | 2025-03-31 |
Before After Market: | After Market |
Currency: | ILA |
Report Date: | 2025-03-05 |
Date: | 2024-12-31 |
Before After Market: | After Market |
Currency: | ILA |
Report Date: | 2024-11-07 |
Date: | 2024-09-30 |
Before After Market: | After Market |
Currency: | ILA |
Report Date: | 2023-03-09 |
Date: | 2022-12-31 |
Currency: | ILA |
Eps Actual: | -0.03 |
Eps Estimate: | -0.04 |
Eps Difference: | 0.01 |
Surprise Percent: | 2 |
Report Date: | 2022-11-10 |
Date: | 2022-09-30 |
Currency: | ILA |
Eps Actual: | -0.04 |
Eps Estimate: | -0.04 |
Report Date: | 2022-08-11 |
Date: | 2022-06-30 |
Currency: | ILA |
Eps Actual: | -0.04 |
Eps Estimate: | -0.04 |
Report Date: | 2022-05-12 |
Date: | 2022-03-31 |
Currency: | ILA |
Eps Actual: | -0.04 |
Eps Estimate: | -0.03 |
Eps Difference: | -0.01 |
Surprise Percent: | -33.33 |
Report Date: | 2022-03-10 |
Date: | 2021-12-31 |
Currency: | ILA |
Eps Actual: | -0.17 |
Eps Estimate: | -0.05 |
Eps Difference: | -0.12 |
Surprise Percent: | -24 |
Report Date: | 2021-11-10 |
Date: | 2021-09-30 |
Currency: | ILA |
Eps Actual: | -0.05 |
Eps Estimate: | -0.05 |
Report Date: | 2021-08-12 |
Date: | 2021-06-30 |
Currency: | ILA |
Eps Actual: | -0.03 |
Eps Estimate: | -0.04 |
Eps Difference: | 0.01 |
Surprise Percent: | 2 |
Report Date: | 2021-05-13 |
Date: | 2021-03-31 |
Currency: | ILA |
Eps Actual: | -0.01 |
Eps Estimate: | -0.04 |
Eps Difference: | 0.03 |
Surprise Percent: | 7 |
Report Date: | 2021-03-11 |
Date: | 2020-12-31 |
Currency: | ILA |
Eps Actual: | 0.01 |
Eps Estimate: | -0.05 |
Eps Difference: | 0.06 |
Surprise Percent: | 12 |
Report Date: | 2020-11-04 |
Date: | 2020-09-30 |
Currency: | ILA |
Eps Actual: | -0.05 |
Eps Estimate: | -0.04 |
Eps Difference: | -0.01 |
Surprise Percent: | -2 |
Report Date: | 2020-08-06 |
Date: | 2020-06-30 |
Currency: | ILA |
Eps Actual: | -0.04 |
Eps Estimate: | -0.04 |
Report Date: | 2020-05-07 |
Date: | 2020-03-31 |
Currency: | ILA |
Eps Actual: | -0.06 |
Eps Estimate: | -0.05 |
Eps Difference: | -0.01 |
Surprise Percent: | -2 |
Report Date: | 2020-03-12 |
Date: | 2019-12-31 |
Currency: | ILA |
Eps Actual: | -0.03 |
Eps Estimate: | -0.05 |
Eps Difference: | 0.02 |
Surprise Percent: | 4 |
Report Date: | 2019-11-12 |
Date: | 2019-09-30 |
Currency: | ILA |
Eps Actual: | -0.12 |
Eps Estimate: | -0.05 |
Eps Difference: | -0.07 |
Surprise Percent: | -14 |
Report Date: | 2019-08-08 |
Date: | 2019-06-30 |
Currency: | ILA |
Eps Actual: | -0.2 |
Eps Estimate: | -0.05 |
Eps Difference: | -0.15 |
Surprise Percent: | -30 |
Report Date: | 2019-05-09 |
Date: | 2019-03-31 |
Currency: | ILA |
Eps Actual: | 0.3 |
Eps Estimate: | -0.06 |
Eps Difference: | 0.36 |
Surprise Percent: | 60 |
Report Date: | 2019-03-14 |
Date: | 2018-12-31 |
Currency: | ILA |
Eps Actual: | -0.32 |
Eps Estimate: | -0.07 |
Eps Difference: | -0.25 |
Surprise Percent: | -357.14 |
Report Date: | 2018-11-08 |
Date: | 2018-09-30 |
Currency: | ILA |
Eps Actual: | -0.09 |
Eps Estimate: | -0.07 |
Eps Difference: | -0.02 |
Surprise Percent: | -28.57 |
Report Date: | 2018-08-02 |
Date: | 2018-06-30 |
Currency: | ILA |
Eps Actual: | -0.03 |
Eps Estimate: | -0.07 |
Eps Difference: | 0.04 |
Surprise Percent: | 57.14 |
Report Date: | 2018-05-10 |
Date: | 2018-03-31 |
Currency: | ILA |
Eps Actual: | -0.5 |
Eps Estimate: | -0.07 |
Eps Difference: | -0.43 |
Surprise Percent: | -614.28 |
Report Date: | 2018-03-15 |
Date: | 2017-12-31 |
Currency: | ILA |
Eps Actual: | -0.58 |
Eps Estimate: | -0.07 |
Eps Difference: | -0.51 |
Surprise Percent: | -728.57 |
Report Date: | 2017-11-09 |
Date: | 2017-09-30 |
Currency: | ILA |
Eps Actual: | 0.12 |
Eps Estimate: | -0.08 |
Eps Difference: | 0.2 |
Surprise Percent: | 25 |
Report Date: | 2017-08-02 |
Date: | 2017-06-30 |
Currency: | ILA |
Eps Actual: | -0.11 |
Eps Estimate: | -0.08 |
Eps Difference: | -0.03 |
Surprise Percent: | -37. |
Report Date: | 2017-05-10 |
Date: | 2017-03-31 |
Currency: | ILA |
Eps Actual: | 0.46 |
Eps Estimate: | -0.09 |
Eps Difference: | 0.55 |
Surprise Percent: | 611.11 |
Report Date: | 2017-03-16 |
Date: | 2016-12-31 |
Currency: | ILA |
Eps Actual: | -0.05 |
Eps Estimate: | -0.14 |
Eps Difference: | 0.09 |
Surprise Percent: | 64.28 |
Report Date: | 2016-11-03 |
Date: | 2016-09-30 |
Currency: | ILA |
Eps Actual: | 0.3 |
Eps Estimate: | -0.14 |
Eps Difference: | 0.44 |
Surprise Percent: | 314.28 |
Report Date: | 2016-08-09 |
Date: | 2016-06-30 |
Currency: | ILA |
Eps Actual: | -0.11 |
Eps Estimate: | -0.17 |
Eps Difference: | 0.06 |
Surprise Percent: | 35.29 |
Report Date: | 2016-05-10 |
Date: | 2016-03-31 |
Currency: | ILA |
Eps Actual: | -0.19 |
Eps Estimate: | -0.14 |
Eps Difference: | -0.05 |
Surprise Percent: | -35.71 |
Report Date: | 2016-03-15 |
Date: | 2015-12-31 |
Currency: | ILA |
Eps Actual: | -0.16 |
Eps Estimate: | -0.17 |
Eps Difference: | 0.01 |
Surprise Percent: | 5.88 |
Report Date: | 2006-08-16 |
Date: | 2006-06-30 |
Currency: | ILA |
Eps Actual: | -0.03 |
Eps Estimate: | -0.02 |
Eps Difference: | -0.01 |
Surprise Percent: | -5 |
Report Date: | 2006-04-18 |
Date: | 2006-03-31 |
Currency: | ILA |
Eps Actual: | -0.03 |
Report Date: | 2005-11-15 |
Date: | 2005-09-30 |
Currency: | ILA |
Eps Actual: | -0.02 |
Eps Estimate: | -0.04 |
Eps Difference: | 0.02 |
Surprise Percent: | 5 |
Report Date: | 2005-08-15 |
Date: | 2005-06-30 |
Currency: | ILA |
Eps Actual: | -0.02 |
Eps Estimate: | -0.04 |
Eps Difference: | 0.02 |
Surprise Percent: | 5 |
Report Date: | 1998-08-15 |
Date: | 1998-06-30 |
Currency: | ILA |
Eps Actual: | -0.08 |
Eps Estimate: | -0.1 |
Eps Difference: | 0.02 |
Surprise Percent: | 2 |
Report Date: | 1998-06-24 |
Date: | 1998-03-31 |
Currency: | ILA |
Eps Actual: | -0.11 |
Eps Estimate: | -0.11 |
Report Date: | 1998-03-19 |
Date: | 1997-12-31 |
Currency: | ILA |
Eps Actual: | -0.06 |
Eps Estimate: | -0.1 |
Eps Difference: | 0.04 |
Surprise Percent: | 4 |
Report Date: | 1997-10-08 |
Date: | 1997-09-30 |
Currency: | ILA |
Eps Actual: | -0.12 |
Eps Estimate: | 0.04 |
Eps Difference: | -0.16 |
Surprise Percent: | -40 |
Report Date: | 1997-07-08 |
Date: | 1997-06-30 |
Currency: | ILA |
Eps Actual: | -0.06 |
Eps Estimate: | -0.06 |
Report Date: | 1997-02-20 |
Date: | 1996-12-31 |
Currency: | ILA |
Eps Actual: | -0.07 |
Eps Estimate: | -0.06 |
Eps Difference: | -0.01 |
Surprise Percent: | -16.66 |
Date: | 2024-09-30 |
Date: | 2022-12-31 |
Eps Actual: | -0.1 |
Date: | 2021-12-31 |
Eps Actual: | -0.2 |
Date: | 2020-12-31 |
Eps Actual: | -0.1 |
Date: | 2019-12-31 |
Eps Actual: | -0.0 |
Date: | 2018-12-31 |
Eps Actual: | -0.9 |
Date: | 2017-12-31 |
Eps Actual: | -0.1 |
Date: | 2016-12-31 |
Eps Actual: | -0.0 |
Date: | 2015-12-31 |
Eps Actual: | -0.4 |
Date: | 1997-12-31 |
Eps Actual: | -0.2 |
Date: | 1996-12-31 |
Eps Actual: | -0.0 |